Tarsus Pharmaceuticals
The Associate Director, Chemical Development leads strategic planning and execution of CMC activities for drug substance development and manufacturing across preclinical to commercial stages, overseeing API operations, CMO collaborations, and supply strategies. This role provides technical and operational leadership, manages budgets, and ensures compliance with regulatory and quality standards.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
Senior Scientist, Chemical Development
Alumis
Executive Director CMC/ Pharmaceutical Development
Clinical Dynamix
Principal Scientist
MSD
Principal Scientist, Long-Acting Injectable Sterile Product Development
MSD
Associate Director or Director of Chemical Engineering
Nurix
Sr. Scientist Analytical Development
Replimune